The sales are small and routine, likely for tax or liquidity purposes following option exercises. No material signal for the stock; monitor upcoming earnings or pipeline catalysts for directional cues.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 2 $25.82entry
- T+1 · yesterday −38.23%α −39.88% · $15.95
- T+2 · todayOpen
- T+5 · in 5d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two C-suite insiders at Nurix Therapeutics (CSO and CLO) sold a combined $208K in open-market sales, with the CSO's sale executed under a 10b5-1 plan. The total is 0.007% of the $3.0B market cap, well below the 0.1% materiality threshold, making this a routine, non-informative cluster.
Key Financial Metrics
Key Facts
- Chief Scientific Officer Gwenn Hansen sold 4.0K shares at $26.28 for $104K under a 10b5-1 plan
- Chief Legal Officer Christine Ring sold 4.0K shares at $26.28 for $104K without a 10b5-1 plan
- Total open-market sales of $208K represent 0.007% of the $3.0B market cap
- Both sales followed derivative exercises (non-cash, $0 value) that generated the shares sold
- No insider purchases in the cluster window
Financial Impact
Total insider sales of $208K, negligible relative to $3.0B market cap
Risk Factors
- Sales by two C-suite insiders could be misread as negative signal by some market participants
- 10b5-1 plan for CSO suggests pre-planned sale, not opportunistic
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NRIX-1793666716832 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 4, 2026 today | Insider Cluster | $17.16 | awaiting T+20 | awaiting T+20 | $15.95 (−7.05%) |
Nov 4, 2026 today | 144 | $15.85 | awaiting T+20 | awaiting T+20 | $15.95 (+0.63%) |
Nov 3, 2026 1d ago | 144 | $16.79 | awaiting T+20 | awaiting T+20 | $15.95 (−5.00%) |
Nov 3, 2026 1d ago | 8-K | $20.05 | awaiting T+20 | awaiting T+20 | $15.95 (+20.45%) |
Nov 2, 2026 1d ago | Insider Cluster | $25.82 | awaiting T+20 | awaiting T+20 | $15.95 (−38.23%) |
Nov 2, 2026 2d ago | 144 | $25.82 | awaiting T+20 | awaiting T+20 | $15.95 (−38.23%) |
Oct 15, 2026 20d ago | Insider Cluster | $24.42 | awaiting T+20 | awaiting T+20 | $15.95 (−34.68%) |
Oct 14, 2026 21d ago | 144 | $24.95 | awaiting T+20 | awaiting T+20 | $15.95 (−36.07%) |
Oct 13, 2026 22d ago | 8-K | $22.13 | awaiting T+20 | awaiting T+20 | $15.95 (−27.93%) |
Oct 5, 2026 4w ago | Press Release | $22.88 $26.80 | ▲ +17.13% | ▲ +19.60% | $15.95 (−30.29%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers